Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Aurobindo
FDA Approves MYCOPHENOLATE MOFETIL — Aurobindo Pharma Limited

Aurobindo Pharma Limited received FDA approval for oral Mycophenolate Mofetil tablets, a key asset in the chronic immunosuppressant market. The launch...

Meitheal
FDA Approves FLUOROURACIL — Meitheal Pharmaceuticals Inc.

# FDA Approves Meitheal Pharmaceuticals' Generic Fluorouracil Intravenous Formulation The U.S. FDA has approved Meitheal Pharmaceuticals Inc.'s abbre...

Genentech,
FDA Approves OCREVUS ZUNOVO — Genentech, Inc.

Genentech, Inc. received FDA clearance for OCREVUS ZUNOVO, a once-monthly subcutaneous formulation of Ocrelizumab combined with recombinant Hyaluronid...

Eli
FDA Approves EBGLYSS — Eli Lilly and Company

Eli Lilly announced the FDA approval of lebelizumab (EBGLYSS) for atopic dermatitis on September 13; the clearance is expected to impact revenue as th...

Somerset
FDA Approves PROCHLORPERAZINE EDISYLATE — Somerset Therapeutics, LLC

Somerset Therapeutics, LLC announced the September 13, 2024 approval of its and for prochlorperazine edisylate, signalling a robust pipeline that posi...

Genentech,
FDA Approves TECENTRIQ HYBREZA — Genentech, Inc.

# FDA Approves Genentech's TECENTRIQ HYBREZA, Expanding Subcutaneous Administration Options for Cancer Immunotherapy Genentech announced FDA approval...

ZYDUS
FDA Approves Unknown Drug — ZYDUS

Following the FDA approval of a new product application, ZYDUS is poised to expand its portfolio following a regulatory green light. This approval is ...

Amgen,
FDA Approves PAVBLU — Amgen, Inc

# FDA Approves Amgen's PAVBLU, First Biosimilar Aflibercept for Retinal Disease Treatment Amgen announced FDA approval of PAVBLU (aflibercept-ayyh), ...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS INC

Teva Pharmaceuticals has received U.S. regulatory approval for their Abbreviated New Drug Application (ANDA213191) on August 22, 2024, marking a signi...

ARS
FDA Approves NEFFY — ARS Pharmaceuticals Operations, Inc.

# FDA Approves ARS Pharmaceuticals' NEFFY, First Nasal Epinephrine Auto-Injector Alternative ARS Pharmaceuticals Operations, Inc. received FDA approv...

Amneal
FDA Approves CREXONT — Amneal Pharmaceuticals LLC

# FDA Approves Amneal Pharmaceuticals' CREXONT for Parkinson's Disease Treatment Amneal Pharmaceuticals LLC received FDA approval for CREXONT (carbid...

SERVIER
FDA Approves Unknown Drug — SERVIER

On August 6, 2024, Servier received FDA approval for the NDA218784 drug, signaling a strategic expansion into a high-value therapeutic market that is ...

Sun
FDA Approves LEQSELVI — Sun Pharmaceutical Industries, Inc.

Sun Pharmaceutical Industries secured FDA approval for the oral deuruxolitinib phosphate formulation branded as LEQSELVI on July 25, 2024, reinforcing...

Teva
FDA Approves EPYSQLI — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA has secured FDA approval for EPYSQLI (eculizumab-aagh) for intravenous administration, a move expected to intensify competiti...

Zydus
FDA Approves ZITUVIMET XR — Zydus Pharmaceuticals USA Inc.

On July 18, Zydus Pharmaceuticals USA Inc. received FDA approval for the extended-release formulation of sitagliptin and metformin hydrochloride table...

STERISCIENCE
FDA Approves SUCCINYLCHOLINE CHLORIDE — STERISCIENCE SPECIALTIES PRIVATE LIMITED

STERISciENCE Specialties Private Limited announced today that the FDA has granted approval for its Abbreviated New Drug Application (#ANDA217873) for ...

FORMYCON
FDA Approves Unknown Drug — FORMYCON AG

FORMYCON AG announced that the FDA has granted approval for its drug, marking a potential new entry into the market with significant implications for ...

Teva
FDA Approves PHENTERMINE AND TOPIRAMATE — Teva Pharmaceuticals, Inc.

Teva Pharmaceuticals’ June 25 approval of its generic phentermine and topiramate extended-release tablets introduces a likely price-competitive altern...

UPSHER
FDA Approves Unknown Drug — UPSHER SMITH LABS

# FDA Approves ANDA for Upsher Smith Labs Upsher Smith Laboratories received FDA approval for ANDA216772 on June 12, 2024, expanding its generic drug...

Apotex
FDA Approves POMALIDOMIDE — Apotex Corp.

# FDA Approves Generic Pomalidomide from Apotex Corp. Apotex Corp. has received FDA approval for its generic version of pomalidomide, an oral immunom...